The Europe biosimilar market size reached USD 13,864 million in 2024 and is projected to grow to USD 59,733.3 million by 2033, with a CAGR of 17.1% from 2025 to 2033. Growth is driven by favorable reimbursement policies, expanded production capacity, and ongoing technological advancements. https://www.imarcgroup.com/europe-biosimilar-market